Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment.
Liljedahl
Ulrika
U
Department of Medical Sciences, Uppsala University, Uppsala University Hospital, Entrance 70, 3rd floor, 751 85 Uppsala, Sweden. Ulrika.Liljedahl@medsci.uu.se
Lind
Lars
L
Kurland
Lisa
L
Berglund
Lars
L
Kahan
Thomas
T
Syvänen
Ann-Christine
AC
D000704:Analysis of Variance; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001055:Apolipoproteins B / Q000235:genetics*; D001262:Atenolol / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D005260:Female; D005838:Genotype; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000235:genetics; D000077405:Irbesartan; D008297:Male; D008875:Middle Aged; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D020641:Polymorphism, Single Nucleotide; D011973:Receptors, LDL / Q000235:genetics*; D013599:Systole / Q000187:drug effects / Q000235:genetics; D013777:Tetrazoles / Q000627:therapeutic use
D000959:Antihypertensive Agents; D001055:Apolipoproteins B; D001713:Biphenyl Compounds; D011973:Receptors, LDL; D013777:Tetrazoles; D001262:Atenolol; D000077405:Irbesartan